Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

 

 

The Lateral Flow Assays Market is bound to witness a robust CAGR going forward. The present scenario is that of prediction of the course of treatment based on data analytics. Technology has been dominating in the form of IoMT (Internet-of-Medical-Things), AI (Artificial Intelligence), cloud computing, predictive analytics, and what not? With the proven advantage of the reduction in casualties and real-time access to the history of patients, and not to forget – remote monitoring, the healthcare industry is there to upturn.

The Lateral Flow Assays Market will witness a CAGR of 5.4%, reaching US$ 9.7 Billion between 2026. With medical IoT implying the use of wearable monitors, devices, and various integrated applications regarding healthcare needs, the healthcare vertical is bound to scale new-fangled heights in the upcoming period. This is what the healthcare vertical would all be in the next 10 years.

Technological preferences and advancements in lateral flow assay kits over the years have resulted in reduced hospital visits, which is expected to contribute to the growth of the global lateral flow assay market. Technological improvements, coupled with increasing awareness, are projected to increase the acceptance of lateral flow assay kits globally.

Lateral flow assay kits are used for the early-stage diagnosis of diseases. According to the latest research by the company, the global lateral flow assay market style=”font-weight: 400;”> is projected to account for over US$ 9.7 Bn in terms of value by the end of 2026.

Strategizing The Moves For The Next Decade? See Through Sample Of Lateral Flow Assays Market Report! https://www.persistencemarketresearch.co/samples/18613

Company Profiles

  • Abbott Laboratories
  • bioMerieux S.A
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers
  • Hologic Inc.
  • F. Hoffmann-La Roche Ltd
  • Others

Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com

The report further projects a 5.4% growth rate with an increasing average Y-o-Y throughout 2026. The lateral flow assay market is expanding and gaining popularity as these tests are simple and can be performed by the patients themselves. These kits provide faster results within few minutes. The lateral flow assay readers match the sensitivity of Elisa tests and eliminate the possibility of human errors.

Factors Impacting Revenue Growth of the Lateral Flow Assay Market

The growing acceptance of smart devices has resulted in the advent of automated smartphone-based readers for lateral flow assay tests. Test images captured with a smartphone camera are processed and stored electronically with information about the patient & operator, and the date & time of each test.

These readers can be used for analyzing various metabolites present in the urine and saliva, blood, serum, plasma and solubilized solids. Ease of use, low costs and ease of production are among factors that have resulted in the expansion of lateral flow assay kits in various fields.

Bench top readers are sophisticated and automated for qualitative as well as quantitative tests. These readers exclude the possibility of human errors that occur due to the visual judgment of colored areas by humans.

Increasing prevalence of infectious diseases, such as mosquito-borne diseases, Streptococcus infections, Tuberculosis (TB) and Sexually Transmitted Infections (STI), is boosting the lateral flow assay market. The presence of a large patient pool in developing regions, such as China and South Africa, and the advent of new lateral flow assays are among factors expected to drive the lateral flow assay market during the forecast period.

Starting With The New Decade On A Diligent Note In The Lateral Flow Assays Market? https://www.persistencemarketresearch.co/methodology/18613

Lateral Flow Assay Market: Competitive Assessment

Companies are increasingly emphasizing on the research and development of drugs and therapies for diseases such as malaria, salmonella, and others, and their early stage diagnosis is expected to create significant growth opportunities for the lateral flow assays market.

Significant collaborations and acquisitions among the key players in the industry, funding programs and the presence of reimbursement agencies is also expected to aid the growth of the market. For instance, in 2016, Abbott acquired Alere, which was one of the major market players in the lateral flow assays.

In addition, manufacturers are joining hands with various organizations to spread awareness about the usage of lateral flow assays. The emergence of diseases, such as Zika virus, Ebola, and other pandemic disease, has increased the procurement of point-of-care testing devices and kits by international bodies, such as UNICEF, which has boosted the lateral flow assay market.

The lateral flow assay market is fragmented in nature with three players accounting for majority of the global revenue. The companies operating in the market are focusing on launching various types of reusable and disposable readers to further increase sensitivity during the diagnosis of diseases.

The manufacturers of lateral flow assays are conducting product awareness and training programs. For instance, in Latin America, Abbott distributed ~8.5 million HIV test kits in Brazil in 2015, and more than 255,000 people were diagnosed with HIV who would have otherwise remained undiagnosed.

However, the tests performed with the help of lateral flow assay kits at different times on the same person are likely to yield quite different results. This factor is expected to negatively impact the growth of the global lateral flow assay market over the forecast period.

How About Obtaining Insights About The Region To Enter Concerning The Lateral Flow Assays Market? Press The “Purchase Now” Button To Have Our Lateral Flow Assays Market Report! https://www.persistencemarketresearch.com/checkout/18613

Segmental Insights on the Lateral Flow Assay Market

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts